UPDATE: Oppenheimer Upgrades Ascendis Pharma (ASND) to Outperform
Tweet Send to a Friend
(Updated - February 14, 2022 5:28 AM EST)
Oppenheimer analyst Leland Gershell upgraded Ascendis Pharma (NASDAQ: ASND) from Perform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershell upgraded Ascendis Pharma (NASDAQ: ASND) from Perform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
